[Long-term outcome of bronchoplastic procedures in the treatment of lung cancer].
OBJECTIVE
To assess the value of bronchoplastic procedures in surgical treatment for bronchogenic carcinoma.


METHODS
Bronchoplastic procedures were performed in 78 patients with bronchogenic carcinoma from August 1976 to December 2002. There were 67 patients with squamous cell carcinoma (86%). Of the total, 57 patients underwent sleeve resection of the right upper lobe (including 2 undergoing bronchoplasty and angioplasty; 2 undergoing partial carinal plus lobar resection); 1 patient had sleeve bilobectomy of the right upper and middle lobes; 2 patients had sleeve bilobectomy of the right middle and lower lobes. Sleeve resection of the left upper lobe was accomplished in 12 patients (including 3, undergoing bronchoplasty and angioplasty), 5 patients had sleeve lobectomy of the left lower lobe. Postoperative pathological staging: 47 in stage I (60.2%), 23 in stage II (29.5%), 8 in stage III (10.3%).


RESULTS
No operative death occurred in 30 days. Complications were noted in 5 patients (6.6%), including pneumonia (2 patients) and atelectasis (3 patients). The overall 5-year survival for 78 patients was 57.8% (26/45), 43% (6/14) respectively. The 5-year survival for patients in stage I, II and III was 68.7% (22/32), 36.4% (4/11) and 0 (0/2) respectively.


CONCLUSIONS
Bronchoplastic procedures for bronchogenic carcinoma extends operative indication to some patients with complication rates comparable to pneumonectomy and improve life quality.
Yu
Chang-hai
CH
Department of Thoracic Surgery, General Hospital of PLA, Beijing 100853, China.
Wang
Yun-xi
YX
Chu
Xiang-yang
XY
Sun
Yu-e
YE
Wang
Tao
T
D000328:Adult; D000368:Aged; D001980:Bronchi / Q000601:surgery*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D019651:Plastic Surgery Procedures / Q000379:methods*; D015996:Survival Rate